CVS HEALTH Corp balance sheet CVS

Annual Quarterly

As of Sep 30, 2026, CVS HEALTH Corp had total assets of $258.1 billion and total liabilities of $177.4 billion. Total assets were up 1.1% from a year earlier. Stockholders' equity was $80.5 billion. It held $49.0 billion in cash and investments against $71.8 billion of total debt, net debt of $22.9 billion. The current ratio, current assets divided by current liabilities, was 0.85.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

Line	FY 2026 Sep 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018	FY 2017 Dec 31, 2017	FY 2016 Dec 31, 2016
Assets
Cash	11,738 +29.0%	8,453 -1.5%	8,586 +4.8%	8,196 -36.7%	12,945 +37.6%	9,408 +19.8%	7,854 +38.2%	5,683 +40.0%	4,059 +139.3%	1,696 -49.7%	3,371 +37.1%
Short-term investments	3,149 +47.6%	2,145 -10.9%	2,407 -26.1%	3,259 +17.3%	2,778 -10.9%	3,117 +3.9%	3,000 +26.4%	2,373 -5.9%	2,522 +2172.1%	111 +27.6%	87 -1.1%
Long-term investments	34,066 +8.0%	32,669 +12.9%	28,934 +25.7%	23,019 +9.1%	21,096 -8.4%	23,025 +10.6%	20,812 +20.2%	17,314 +10.1%	15,732	—	—
Cash and investments	48,953 +14.4%	43,267 +8.4%	39,927 +15.8%	34,474 -6.4%	36,819 +3.6%	35,550 +12.3%	31,666 +24.8%	25,370 +13.7%	22,313 +1134.8%	1,807 -47.7%	3,458 +35.8%
Receivables	42,073 -4.1%	39,779 +9.1%	36,469 +3.5%	35,227 +29.2%	27,276 +11.6%	24,431 +12.4%	21,742 +10.8%	19,617 +11.3%	17,631 +33.8%	13,181 +8.4%	12,164 +2.3%
Inventory	18,240 -3.8%	19,246 +6.3%	18,107 +0.5%	18,025 -5.6%	19,090 +7.5%	17,760 -4.0%	18,496 +5.6%	17,516 +6.5%	16,450 +7.5%	15,296 +3.6%	14,760 +5.4%
Total current assets	79,392 +3.0%	74,714 +8.8%	68,645 +1.2%	67,858 +3.4%	65,633 +9.4%	60,008 +6.5%	56,369 +12.1%	50,302 +11.2%	45,243 +44.9%	31,229 +0.6%	31,042 +6.5%
Property and equipment, net	13,322 +3.8%	13,083 +0.7%	12,993 -1.4%	13,183	—	—	—	—	—	—	—
Goodwill	85,478 +0.0%	85,478 -6.3%	91,272 +0.0%	91,272 +16.8%	78,150 -1.2%	79,121 -0.5%	79,552 -0.2%	79,749 +1.4%	78,678 +104.6%	38,451 +0.5%	38,249 +0.4%
Total assets	258,075 +1.1%	253,538 +0.1%	253,215 +1.4%	249,728 +9.4%	228,275 -2.0%	232,999 +1.0%	230,715 +3.7%	222,449 +13.2%	196,456 +106.5%	95,131 +0.7%	94,462 +2.2%
Liabilities and equity
Accounts payable	—	—	—	—	—	—	—	—	—	8,863 +11.5%	7,946 +6.1%
Total current liabilities	93,097 +0.4%	88,692 +4.8%	84,609 +6.8%	79,189 +14.1%	69,421 +2.4%	67,807 +9.3%	62,017 +16.3%	53,303 +21.1%	44,009 +43.6%	30,648 +16.8%	26,250 +13.3%
Total liabilities	177,386 -2.7%	178,156 +0.4%	177,485 +2.5%	173,092 +10.6%	156,506 -0.7%	157,618 -2.1%	161,014 +1.7%	158,279 +14.8%	137,913	—	—
Stockholders' equity	80,497 +10.4%	75,214 -0.5%	75,560 -1.2%	76,461 +7.0%	71,469 -4.8%	75,075 +8.2%	69,389 +8.7%	63,864 +9.7%	58,225 +54.5%	37,691 +2.3%	36,830 -1.0%
Debt
Debt due within a year	57,223 +4488.9%	0 -100.0%	2,119 +959.5%	200 -99.6%	49,011 -3.3%	50,671 -12.8%	58,124 +1437.3%	3,781 +39.8%	2,705 -55.6%	6,097 +211.2%	1,959 +58.9%
Long-term debt	—	—	—	—	—	—	—	—	71,444 +222.1%	22,181 -13.4%	25,615 -2.5%
Lease liabilities	14,617 -15.4%	16,706 -7.2%	18,010 -6.0%	19,166 -4.2%	20,003 -5.3%	21,123 -1.7%	21,478 +0.7%	21,330 +7829.4%	269	—	—
Total debt	71,840 +287.9%	16,706 -17.0%	20,129 +3.9%	19,366 -71.9%	69,014 -3.9%	71,794 -9.8%	79,602 -17.5%	25,111 -66.3%	74,418 +163.2%	28,278 +2.6%	27,574 +0.3%
Net cash	-22,887 -194.3%	26,561 +34.2%	19,798 +31.0%	15,108 +146.9%	-32,195 +11.2%	-36,244 +24.4%	-47,936 +32.6%	259 +100.5%	-52,105 -96.8%	-26,471 -9.8%	-24,116 +3.4%
Ratios
Current ratio	0.85x	0.84x	0.81x	0.86x	0.95x	0.88x	0.91x	0.94x	1.03x	1.02x	1.18x
Debt to equity	0.89x	0.22x	0.27x	0.25x	0.97x	0.96x	1.15x	0.39x	1.28x	0.75x	0.75x
Debt to EBITDA	3.67x	1.80x	1.54x	1.07x	5.67x	4.03x	4.34x	1.54x	11.04x	2.35x	—
Return on equity	13.71%	2.35%	6.11%	10.91%	6.03%	10.66%	10.35%	10.39%	-1.02%	17.57%	14.44%
Return on assets	4.28%	0.70%	1.82%	3.34%	1.89%	3.43%	3.11%	2.98%	-0.30%	6.96%	5.63%
Book value per share	62.89	59.18	59.97	59.36	54.98	56.79	52.97	49.05	44.96	37.17	34.71

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.

Company profile

Industry: Retail-Drug Stores and Proprietary Stores (SIC 5912)
Listed as: CVS (NYSE)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Woonsocket, RI
SEC filer status: Large accelerated filer
SEC CIK: 64803
Former names: CVS CAREMARK CORP (until Sep 3, 2014); CVS/CAREMARK CORP (until May 8, 2007); CVS CORP (until Mar 22, 2007); MELVILLE CORP (until Jan 10, 1997)

Other Retail-Drug Stores and Proprietary Stores companies

All 6 Retail-Drug Stores and Proprietary Stores companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.